	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S103-PMC3004407	PMC3004407	12/2010	S103-PMC3004407	['specifically, obesity and race DEMONSTRATED a significant ASSOCIATION with Vitamin D category, and obesity retained a significant RELATIONSHIP with Vitamin D category after controlling for race ( p = .01).']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 130)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
S59-PMC3075531	PMC3075531	7/2010	S59-PMC3075531	['one option WOULD BE a national or multinational study based on randomization of school districts or other suitable units in regions of low sunlight intensity, PERHAPS including multiple outcomes that MIGHT be AFFECTED by Vitamin D, such as diabetes, obesity, Respiratory infections, and asthma.4546ALTERNATIVELY, high-risk first-degree relatives of individu-als with ms COULD BE targeted in a smaller trial,47ALTHOUGH randomization and compliance COULD BE more CHALLENGING.']	[('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('FUTURE_WORK', 370), ('ANOMALY_CURIOUS_FINDING', 409), ('FUTURE_WORK', 447), ('DIFFICULT_TASK', 461)]	9	[('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 259, 'respiratory')]
S43-PMC3257641	PMC3257641	3/2010	S43-PMC3257641	['furthermore, SINCE 25(Oh)D is stored in Adipose Tissue, there is SOME EVIDENCE that obesity is a FURTHER RISK FACTOR for Vitamin D insufficiency.nutrients-02-00389-t001_table 1\n\ncaption (table-wrap): table 1\n\nrisk factors for Vitamin D deficiency.low ambient uvr level high latitude locationwinter season inadequate sun exposure built or indoor environmentextensive clothing cover (e.g., veiled)excess sun avoidance – (shade, sunscreen) host factors dark skin pigmentationold ageobesitymalabsorptive syndromes (e.g., inflammatory Bowel disease)\nMANY STUDIES HAVE REPORTED on the Vitamin D status of Pregnant women, in a range of environments (summarized intable 2, including studies from 1997–2006).']	[('PROBLEM_COMPLICATION', 13), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 558)]	6	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('UBERON_0001013', 'adipose tissue', 40, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000160', 'intestine', 530, 'bowel'), ('CHEBI_27300', 'vitamin D', 579, 'vitamin D'), ('GO_0007565', 'female pregnancy', 599, 'pregnant')]
S31-PMC3277098	PMC3277098	12/2011	S31-PMC3277098	['this ASSOCIATION persists after adjusting for physical activity and dietary intake SUGGESTING obesity is an INDEPENDENT risk factor for reduced Serum 25(Oh)D and SUPPORTS the notion that Vitamin D deficiency MAY follow from modern lifestyle change.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 208)]	5	[('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 150, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
S111-PMC3356951	PMC3356951	4/2012	S111-PMC3356951	['[85]\n\nobesity\nlow concentrations of circulating Vitamin D are common with obesity and MAY represent a POTENTIAL mechanism EXPLAINING the elevated risk of certain cancers and Cardiovascular outcomes.']	[('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 122)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 174, 'cardiovascular')]
S155-PMC3366611	PMC3366611	4/2012	S155-PMC3366611	['a modest negative ASSOCIATION between maternal bmi and diet quality HAS BEEN IDENTIFIED [131], and obesity is ASSOCIATED with lower levels of Vitamin D [132] and Folic Acid levels during the Childbearing years [133], which MAY increase the risk of Insulin resistance and Neural Tube defects, respectively [134].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 223)]	5	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_30751', 'formic acid', 162, 'folic acid'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 191, 'childbearing'), ('PR_000045358', 'insulin family protein', 248, 'insulin'), ('UBERON_0001049', 'neural tube', 271, 'neural tube')]
S18-PMC3424155	PMC3424155	8/2012	S18-PMC3424155	['moreover, Vitamin D is ASSOCIATED with premature births, obesity and Renal dysfunction in Adulthood, making it more than an ESSENTIAL fat-soluble Vitamin RESPONSIBLE for calcium Metabolism[9],[10].']	[('SUPERFICIAL_RELATIONSHIP', 23), ('IMPORTANT_CONSIDERATION', 124), ('PROBABLE_UNDERSTANDING', 154)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002113', 'kidney', 69, 'renal'), ('UBERON_0000113', 'post-juvenile adult stage', 90, 'adulthood'), ('CHEBI_33229', 'vitamin (role)', 146, 'vitamin'), ('GO_0008152', 'metabolic process', 178, 'metabolism')]
S172-PMC3424155	PMC3424155	8/2012	S172-PMC3424155	['Vitamin D deficiency during the third Trimester of Pregnancy in Humans HAS BEEN ASSOCIATED with Cardiovascular disease, diabetes and obesity in offspring[23], which COULD BE LINKED to the POTENTIAL ROLE of Vitamin D in the Regulation Of Adiposity[24],[25].']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 188), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 223)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0009294', 'DNA mediated transformation', 38, 'trimester'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 64, 'humans'), ('UBERON_0004535', 'cardiovascular system', 96, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0045752', 'positive regulation of Toll signaling pathway', 223, 'regulation of adiposity')]
S9-PMC3427192	PMC3427192	4/2012	S9-PMC3427192	['indeed, numerous dietary hypotheses HAVE BEEN PROPOSED.13-15among the Nutrients and antioxidants included in this HYPOTHESIS, Vitamin D is of particular INTEREST SINCE Vitamin D concentrations decrease with increased time spent indoors, decreased exposure to sunlight, less exercise, obesity, and inadequate Calcium intake.16additionally, a GROWING BODY of literature SUGGESTS that there is a RELATIONSHIP between Vitamin D status and asthma-RELATED Respiratory symptoms,17-22PRESUMABLY through the immunomodulatory EFFECTS of Vitamin D.23,24this brief review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on EMERGING Human STUDIES over the past decade.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 153), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 341), ('INCOMPLETE_EVIDENCE', 368), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 442), ('ANOMALY_CURIOUS_FINDING', 474), ('SUPERFICIAL_RELATIONSHIP', 516), ('SUPERFICIAL_RELATIONSHIP', 586), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 645)]	14	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 308, 'calcium'), ('CHEBI_27300', 'vitamin D', 414, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 450, 'respiratory'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 570, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 654, 'human')]
S53-PMC3427192	PMC3427192	4/2012	S53-PMC3427192	['Vitamin D in Adults with asthma\nin Adults, the RECOMMENDED dietary intake for Vitamin D ranges from 600 to 800 iu daily.47HOWEVER, DESPITE the large variety of Foods supplemented with Vitamin D, a large proportion of the Adult population remains Vitamin D deficient,77,78perhaps DUE IN PART to INADEQUATE sun exposure and the rising PREVALENCE of obesity which CAN LEAD TO decreased Vitamin D bioavailability.79SIMILAR to the studies in school age children, a NUMBER OF cross-sectional studies in Adults have also DEMONSTRATED ASSOCIATIONS between Vitamin D status and asthma Control (table 3).']	[('FUTURE_WORK', 47), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 279), ('INCOMPLETE_EVIDENCE', 283), ('IMPORTANT_CONSIDERATION', 294), ('IMPORTANT_CONSIDERATION', 333), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 365), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 460), ('INCOMPLETE_EVIDENCE', 514), ('SUPERFICIAL_RELATIONSHIP', 527)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 13, 'Adults'), ('UBERON_0007023', 'adult organism', 35, 'adults'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33290', 'food', 160, 'foods'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0007023', 'adult organism', 221, 'adult'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('UBERON_0007023', 'adult organism', 497, 'adults'), ('CHEBI_27300', 'vitamin D', 548, 'vitamin D'), ('GO_0065007', 'biological regulation', 576, 'control')]
S70-PMC3659910	PMC3659910	1/2013	S70-PMC3659910	['pre-Pregnancy obesity is also ASSOCIATED with significant increases in the odds of maternal and neonatal Vitamin D deficiency, INDEPENDENT of other FACTORS such as ethnicity.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 148)]	3	[('GO_0007565', 'female pregnancy', 4, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
S2-PMC3672018	PMC3672018	5/2013	S2-PMC3672018	['the PRESENT STUDY includes an in-depth examination of the INFLUENCE of exposure to Vitamin D early in Life for development of fractures of the Wrist, Arm and Clavicle; obesity, and type 1 diabetes (t1d) during child- and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000104', 'life cycle', 102, 'life'), ('UBERON_0004452', 'carpal region', 143, 'wrist'), ('UBERON_0001460', 'arm', 150, 'arm'), ('UBERON_0001105', 'clavicle bone', 158, 'clavicle'), ('UBERON_0000113', 'post-juvenile adult stage', 221, 'adulthood')]
S20-PMC3672018	PMC3672018	5/2013	S20-PMC3672018	['low Vitamin D during Gestation and in early Life MAY THEREFORE play an IMPORTANT ROLE for susceptibility to bone fragility, obesity and Autoimmune diseases later in Life [6].']	[('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 53), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 21, 'gestation'), ('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0001442', 'skeleton of manus', 136, 'autoimmune'), ('UBERON_0000104', 'life cycle', 165, 'life')]
S35-PMC3672018	PMC3672018	5/2013	S35-PMC3672018	['obesity MAY BE PARTICULARLY ASSOCIATED with low Vitamin D during the third Trimester when Adipose Tissue is formed; fractures MAY BE PARTICULARLY ASSOCIATED with low Vitamin D during the third and/or second trimester [13]; and t1d with low Vitamin D during the first trimester.']	[('INCOMPLETE_EVIDENCE', 8), ('ANOMALY_CURIOUS_FINDING', 15), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 126), ('ANOMALY_CURIOUS_FINDING', 133), ('SUPERFICIAL_RELATIONSHIP', 146)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 75, 'trimester'), ('UBERON_0001013', 'adipose tissue', 90, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
S39-PMC3672018	PMC3672018	5/2013	S39-PMC3672018	['SOME STUDIES have FOUND that Adult obesity varies as a function of month of Birth and that subjects Born from winter to spring become more obese, POSSIBLY due to low Vitamin D levels from restricted maternal sun exposure during the third Trimester of Pregnancy [16].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 146)]	3	[('UBERON_0007023', 'adult organism', 29, 'adult'), ('GO_0007567', 'parturition', 76, 'birth'), ('GO_0007567', 'parturition', 100, 'born'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 238, 'trimester'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
S41-PMC3672018	PMC3672018	5/2013	S41-PMC3672018	['ALTHOUGH mechanisms RELATING low Perinatal Vitamin D to later obesity are NOT WELL KNOWN, PROPOSED mediators include epigenetic changes leading to initiation of Adipogenesis, or induction of permanent functional changes in Hypothalamic Appetite Regulation [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('GO_0036268', 'swimming', 33, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 33, 'perinatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 161, 'adipogenesis'), ('UBERON_0001898', 'hypothalamus', 223, 'hypothalamic'), ('GO_0034205', 'amyloid-beta formation', 236, 'appetite regulation')]
S51-PMC3672018	PMC3672018	5/2013	S51-PMC3672018	['initially the PRESENT STUDY will include an in-depth examination of the INFLUENCE of exposure to Vitamin D during Pregnancy for development of fractures of the Wrist, forearm, upper Arm and Shoulder, as well as fractures of Ankle; development of obesity; and development of t1d during child- and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy'), ('UBERON_0004452', 'carpal region', 160, 'wrist'), ('UBERON_0001460', 'arm', 182, 'arm'), ('UBERON_0001467', 'shoulder', 190, 'shoulder'), ('UBERON_0004454', 'tarsal region', 224, 'ankle'), ('UBERON_0000113', 'post-juvenile adult stage', 296, 'adulthood')]
S65-PMC3672018	PMC3672018	5/2013	S65-PMC3672018	['databases\nin a first effort, we will EXAMINE INFLUENCE of additional early exposure to Vitamin D on subsequent development of fractures, obesity, and t1d.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
S101-PMC3672018	PMC3672018	5/2013	S101-PMC3672018	['for instance, INFLUENCE of low Vitamin D on obesity and Adipose Tissues MAY BE particularly IMPORTANT for children whose third Gestation periods occur during winter, WHILE INFLUENCE of low Vitamin D on Autoimmune diseases MAY BE particularly IMPORTANT for children whose first Gestational trimester occurs during winter.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('SUPERFICIAL_RELATIONSHIP', 172), ('INCOMPLETE_EVIDENCE', 222), ('IMPORTANT_CONSIDERATION', 242)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 56, 'adipose tissues'), ('GO_0007565', 'female pregnancy', 127, 'gestation'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 202, 'autoimmune'), ('GO_0007565', 'female pregnancy', 277, 'gestational')]
S0-PMC3685533	PMC3685533	6/2013	S0-PMC3685533	['Vitamin D status in Cord Blood and newborns: ethnic differences\n\nabstract\n\nbackground\na deficiency in Vitamin D (25Ohd) is common throughout the world in both Adults and children, being RELATED to skin pigmentation, sun exposure, dietary intake and obesity.']	[('SUPERFICIAL_RELATIONSHIP', 186)]	1	"[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 113, '25OHD'), ('UBERON_0007023', 'adult organism', 159, 'adults')]"
S3-PMC3717170	PMC3717170	5/2013	S3-PMC3717170	['THIS REPORT summarizes RECENT RESEARCH on the ROLES for Vitamin D in cancer, Immunity and Autoimmune diseases, Cardiovascular and Respiratory health, Pregnancy, obesity, Erythropoiesis, diabetes, muscle function, and Aging.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007566', 'embryo implantation', 77, 'immunity'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 111, 'cardiovascular'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0030218', 'erythrocyte differentiation', 170, 'erythropoiesis'), ('GO_0007568', 'aging', 217, 'aging')]
S77-PMC3717170	PMC3717170	5/2013	S77-PMC3717170	['Vitamin D and obesity\nigor n. sergeev (south dakota state university) DISCUSSED the POSSIBILITY of integrating Vitamin D supplementation with current STRATEGIES in the PREVENTION and treatment of obesity.']	[('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 84), ('FUTURE_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
S85-PMC3717170	PMC3717170	5/2013	S85-PMC3717170	['the 1,25(Oh)2D3-induced increase in cellular Ca2+is also ASSOCIATED with reduced Lipid accumulation in mature Adipocytes.23in prelimary BUT ongoing STUDIES, a Murine diet-induced obesity (dio) MODEL is being used to evaluate the ROLE of Vitamin D in adiposity.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 229)]	5	[('CHEBI_72779', '11-trans-LTE4', 4, '1,25(OH)2D3'), ('CHEBI_29108', 'calcium(2+)', 45, 'Ca2+'), ('CHEBI_18059', 'lipid', 81, 'lipid'), ('CL_0000136', 'fat cell', 110, 'adipocytes'), ('NCBITaxon_39107', 'Murinae', 159, 'murine'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
S90-PMC3717170	PMC3717170	5/2013	S90-PMC3717170	['the PRELIMINARY results also SUGGEST that high Vitamin D and Calcium intake decreases body and fat weight gain in diet-induced obesity, and that the POTENTIAL mechanism of these effects involves activation of a Ca2+-mediated apoptotic Pathway in Adipose Tissue (specifically, normalization of the activities of apoptotic proteases Ca2+-dependent calpain and Ca2+/calpain-dependent Caspase-12 that are reduced in obesity).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 149)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 61, 'calcium'), ('CHEBI_81233', 'Schizonepetoside B', 211, 'Ca2+-'), ('GO_0051324', 'prophase', 235, 'pathway'), ('UBERON_0001013', 'adipose tissue', 246, 'adipose tissue'), ('CHEBI_81233', 'Schizonepetoside B', 331, 'Ca2+-'), ('CHEBI_32588', 'potassium chloride', 358, 'Ca2'), ('PR_000002319', 'catenin beta-1 isoform 1', 381, 'caspase-12')]
S91-PMC3717170	PMC3717170	5/2013	S91-PMC3717170	['targeting Ca2+Signaling and the Vitamin D/Ca2+–dependent calpains and caspases in Adipocytes with Vitamin D supplementation MAY THEREFORE be an effective and affordable approach for chemoprevention and treatment of obesity.']	[('INCOMPLETE_EVIDENCE', 124), ('PROBABLE_UNDERSTANDING', 128)]	2	[('CHEBI_29108', 'calcium(2+)', 10, 'Ca2+'), ('GO_0016215', 'acyl-CoA desaturase activity', 10, 'Ca2'), ('GO_0023051', 'regulation of signaling', 14, 'signaling'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_51231', 'DAPI', 42, 'Ca2+–'), ('CL_0000136', 'fat cell', 82, 'adipocytes'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
S92-PMC3717170	PMC3717170	5/2013	S92-PMC3717170	['ADDITIONAL STUDIES ARE WARRANTED to evaluate this approach from a safety POINT OF VIEW and to identify the OPTIMAL levels of Calcium and Vitamin D intakes in obesity.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 73), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 125, 'calcium'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
S171-PMC3717170	PMC3717170	5/2013	S171-PMC3717170	['there is STRONG EVIDENCE that obesity is ASSOCIATED with POOR Vitamin D status due to fat sequestration.48in fact, compared with the non-obese, higher doses of Vitamin D are REQUIRED in obese Individuals.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('NCBITaxon_1', 'root', 192, 'individuals')]
S173-PMC3717170	PMC3717170	5/2013	S173-PMC3717170	['HOWEVER, some recent DATA SUGGEST that low Vitamin D PREDICTS an accelerated increase in fat mass and incident obesity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
S21-PMC3760821	PMC3760821	9/2013	S21-PMC3760821	['hypovitaminosis D is commonly SEEN in both Pregnant and non-Pregnant women worldwide[5]; with many FACTORS IMPACTING on Vitamin D status, including; exposure to sunlight, skin colour, season, latitude and obesity, among others[6].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('GO_0007565', 'female pregnancy', 43, 'pregnant'), ('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
S184-PMC3760821	PMC3760821	9/2013	S184-PMC3760821	['in conclusion, the FINDING that Vitamin D DEPENDENT processes MAY BE negatively IMPACTED by maternal nutritional status and obesity in a t1dm cohort is a significant one and provides FURTHER EVIDENCE that population-based INTERVENTIONS aimed at reducing obesity and improving pre-Pregnancy and Gestational Vitamin D status ARE NEEDED.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 80), ('FUTURE_WORK', 183), ('INCOMPLETE_EVIDENCE', 183), ('FUTURE_WORK', 222), ('FUTURE_WORK', 323)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 280, 'pregnancy'), ('GO_0007565', 'female pregnancy', 294, 'gestational'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
S4-PMC3827489	PMC3827489	10/2013	S4-PMC3827489	['the RISK FACTORS for Vitamin D insufficiency or deficiency in the pediatric population are season (winter), insufficient time spent outdoors, ethnicity (non-white), older age, more advanced stage of puberty, obesity, low milk Consumption, low socioeconomic status, and female gender.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007631', 'feeding behavior', 226, 'consumption')]
S21-PMC3827489	PMC3827489	10/2013	S21-PMC3827489	['the wide variety of nonskeletal diseases in which Vitamin D is IMPORTANT include Cardiovascular diseases3), obesity4), Metabolic syndrome5), Insulin resistance6), infection7), allergy8,9), some forms of cancers10-12), and Autoimmune diseases13).']	[('IMPORTANT_CONSIDERATION', 63)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 81, 'cardiovascular'), ('GO_0008152', 'metabolic process', 119, 'metabolic'), ('PR_000045358', 'insulin family protein', 141, 'insulin'), ('UBERON_0001442', 'skeleton of manus', 222, 'autoimmune')]
S47-PMC3827489	PMC3827489	10/2013	S47-PMC3827489	['low Vitamin D status in black Individuals MAY BE ATTRIBUTED MAINLY to decreased skin Synthesis Of Vitamin D due to greater skin pigmentation32)OR to the high prevalence of obesity in black populations25,33,34).']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 49), ('PROBABLE_UNDERSTANDING', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0030474', 'spindle pole body duplication', 85, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
S79-PMC3827489	PMC3827489	10/2013	S79-PMC3827489	['SOME obesity-related health consequences HAVE BEEN CORRELATED with Vitamin D deficiency or insufficiency5,52-54), and RECENT reports have SUGGESTED that Vitamin D supplementation MAY reduce these RISKS, ALTHOUGH the data are INCONSISTENT55,56).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 196), ('ANOMALY_CURIOUS_FINDING', 203), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225)]	9	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
S198-PMC3873449	PMC3873449	12/2013	S198-PMC3873449	['obesity is a RISK FACTOR for Vitamin D deficiency [47].']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
S631-PMC4113768	PMC4113768	7/2014	S631-PMC4113768	['; kiely, m.\nbackground: obesity is a RISK FACTOR for low circulating 25-Hydroxy Vitamin D (25(Oh)D), which is the BIOMARKER of Vitamin D status, and there are CONSISTENT negative ASSOCIATIONS between 25(Oh)D and measures of adiposity in Adults and children.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 179)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 69, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('UBERON_0007023', 'adult organism', 237, 'adults')]
S2351-PMC4113768	PMC4113768	7/2014	S2351-PMC4113768	['conclusion: the results SUGGEST that a modest increase in Vitamin D levels among overweight and obese subjects through the promotion of lifestyle changes for one year have marginal EFFECTS in bone turnover markers as well as obesity itself.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 181)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
S211-PMC4169453	PMC4169453	9/2014	S211-PMC4169453	['in the light of the aforementioned studies, Vitamin D supplements SEEMS to be more effective as a source of Vitamin D in many contemporary industrialized populations SUFFERING from changing lifestyles (restricted sun exposure, obesity, unhealthy diet).']	[('ANOMALY_CURIOUS_FINDING', 66), ('IMPORTANT_CONSIDERATION', 166)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
S94-PMC4340999	PMC4340999	3/2015	S94-PMC4340999	['for latitudes with distinct seasonal changes in availability of uvb, there is a WELL-DOCUMENTED seasonal cycle in Vitamin D status, with a maximum in late summer and a minimum in late winter.32low Vitamin D during Gestation MAY STRONGLY INFLUENCE susceptibility to obesity later in Life.33\nhowever, relatively LITTLE IS KNOWN about the critical period of fetal growth at which low Vitamin D is of particular IMPORTANCE.']	[('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 224), ('PROBABLE_UNDERSTANDING', 228), ('SUPERFICIAL_RELATIONSHIP', 237), ('FULL_UNKNOWN', 310), ('IMPORTANT_CONSIDERATION', 408)]	7	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestation'), ('UBERON_0000104', 'life cycle', 282, 'life'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
S95-PMC4340999	PMC4340999	3/2015	S95-PMC4340999	['low Vitamin D during the second or third Trimester of Pregnancy HAS BEEN SUGGESTED to be ASSOCIATED with Adult obesity.31,33in THE CURRENT STUDY, spring and early summer peaks and winter troughs for bmi and wc were evident.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 127)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 41, 'trimester'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('UBERON_0007023', 'adult organism', 105, 'adult')]
S109-PMC4340999	PMC4340999	3/2015	S109-PMC4340999	['results in the PRESENT STUDY IMPLY that Prenatal Vitamin D status MIGHT be a POTENTIAL pathway LINKING ll with Adult risks of obesity39,40and a range of chronic diseases.8–10HOWEVER, seasonal variation in ll DEPENDING ON region SUGGESTS that ll CAN ONLY be used as anthropometric BIOMARKER of Prenatal Vitamin D status in SOME geographic regions.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 29), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 245), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 280), ('INCOMPLETE_EVIDENCE', 322)]	12	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 293, 'prenatal'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
S125-PMC4340999	PMC4340999	3/2015	S125-PMC4340999	['this is also the FIRST-ever population-BASED EVIDENCE LINKING low Prenatal sun-RELATED uvb exposure (and lower Vitamin D by PROXY) to ll and the susceptibility to obesity later in Life and also SUGGESTING that late second and early third trimesters MIGHT be a CRITICAL period for the above-mentioned EFFECTS ALTHOUGH such EVIDENCE is non-specific, it WARRANTS FURTHER STUDIES in this AREA.']	[('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 249), ('IMPORTANT_CONSIDERATION', 260), ('SUPERFICIAL_RELATIONSHIP', 300), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('INCOMPLETE_EVIDENCE', 322), ('FUTURE_WORK', 351), ('FUTURE_WORK', 360), ('FUTURE_WORK', 384)]	15	[('GO_0007565', 'female pregnancy', 66, 'prenatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
S7-PMC4380518	PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
S48-PMC4380518	PMC4380518	9/2014	S48-PMC4380518	['both overweight/obesity as well as darker skin pigmentation are both WELL-ESTABLISHED RISK FACTORS for Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 69), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
S118-PMC4405493	PMC4405493	4/2015	S118-PMC4405493	['RISK FACTORS for Vitamin D deficiency include INADEQUATE sun or uv light exposure, physiologic factors (such as dark skin pigmentation, obesity, Pregnancy, certain medical problems), and low Vitamin D intake [2–3].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 46)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
S162-PMC4405493	PMC4405493	4/2015	S162-PMC4405493	['obesity is also a KNOWN RISK FACTOR for Vitamin D deficiency[73].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 24)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
S525-PMC4448820	PMC4448820	5/2015	S525-PMC4448820	['caption (boxed-text): text box 19\u2003\nwg 2 summary and conclusions\n\n● the review uses data on 3 Micronutrients (Vitamin A, zinc, and iron), anthropometrically defined undernutrition (stunting, wasting, and underweight), and obesity TO EVALUATE the EFFECT on the following:\n○ Immune function,\n○ recovery of immune function in response to nutritional interventions,\n○ RELATED health outcomes (e.g., risk of infection), and\n○ MARKERS of inflammation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('SUPERFICIAL_RELATIONSHIP', 245), ('SUPERFICIAL_RELATIONSHIP', 363), ('SUPERFICIAL_RELATIONSHIP', 420)]	4	[('CHEBI_33839', 'macromolecule', 93, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('UBERON_0002405', 'immune system', 272, 'immune')]
S538-PMC4448820	PMC4448820	5/2015	S538-PMC4448820	['THIS REVIEW includes examples of undernutrition, including undernutrition defined by poor growth (i.e., underweight, stunting, and wasting) and deficiencies of specific Micronutrients (Vitamin A, zinc, and iron) as well as overnutrition, focusing on obesity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0)]	1	[('CHEBI_33839', 'macromolecule', 169, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin A')]
S1001-PMC4448820	PMC4448820	5/2015	S1001-PMC4448820	['a range of nutritional disturbances is CONSIDERED, including obesity, weight loss, muscle wasting, Adipose Tissue accumulation, and specifically, Micronutrients and Vitamins A and d (figure 1).']	[('INCOMPLETE_EVIDENCE', 39)]	1	[('UBERON_0001013', 'adipose tissue', 99, 'adipose tissue'), ('CHEBI_33839', 'macromolecule', 146, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 165, 'vitamins A')]
S1106-PMC4448820	PMC4448820	5/2015	S1106-PMC4448820	['studies USUALLY DESCRIBE HOW infection and inflammation are ASSOCIATED with nutritional deficiencies [e.g., iron, Vitamin B-12, Folate, and Vitamin D for bacterial vaginosis (637–639) and anemia or obesity for stillbirths (640)].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 16), ('EXPLICIT_QUESTION', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 114, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 114, 'vitamin B-12'), ('CHEBI_30863', '5-azaorotic acid', 128, 'folate'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
S8-PMC4488777	PMC4488777	5/2015	S8-PMC4488777	['MOST experts agree that Vitamin D supplementation is a necessity, PARTICULARLY in women suffering from obesity, Insulin resistance or small Ovarian reserve, as well as in men with oligo- and asthenozoospermia if Serum concentration should fall below 50 nmol/l (normal range up to 125 nmol/l).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 66)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('PR_000045358', 'insulin family protein', 112, 'insulin'), ('UBERON_0000992', 'ovary', 140, 'ovarian'), ('UBERON_0001977', 'blood serum', 212, 'serum')]
S293-PMC4490503	PMC4490503	6/2015	S293-PMC4490503	['Vitamin D\nlow Vitamin D HAS BEEN IMPLICATED in the aetiology of obesity, Insulin resistance and t2dm [121].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('PR_000045358', 'insulin family protein', 73, 'insulin')]
S0-PMC4516377	PMC4516377	6/2015	S0-PMC4516377	['Calcium intake, Serum Vitamin D and obesity in children: IS there an ASSOCIATION?']	[('EXPLICIT_QUESTION', 57), ('SUPERFICIAL_RELATIONSHIP', 69), ('EXPLICIT_QUESTION', 80)]	3	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('UBERON_0001977', 'blood serum', 16, 'serum'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
S1-PMC4516377	PMC4516377	6/2015	S1-PMC4516377	['abstract\n\nobjective:\nTO EVALUATE the ASSOCIATION between Calcium intake and Serum Vitamin D levels and childhood obesity by an integrative review.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 57, 'calcium'), ('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
S3-PMC4516377	PMC4516377	6/2015	S3-PMC4516377	"[""we used the combined terms in english: ''children'' and ''calcium'' or ''children'' and ''Vitamin D'' ASSOCIATED with the descriptors: ''obesity'', ''adiposity'' or ''body fat'' for all bases.""]"	[('SUPERFICIAL_RELATIONSHIP', 102)]	1	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
S9-PMC4516377	PMC4516377	6/2015	S9-PMC4516377	['conclusions:\nthe studies reviewed SHOWED an ASSOCIATION between Calcium and Vitamin D with childhood obesity.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 64, 'calcium'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S13-PMC4516377	PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
S33-PMC4516377	PMC4516377	6/2015	S33-PMC4516377	['studies that evaluated the ASSOCIATION between Calcium or Vitamin D and obesity in children, 2001-2014.authors/year of publicationcountrystudy designpopulation/samplemain resultscalciumcarruth & skinner12(2001)usalongitudinal (retrospective)caucasian children, followed from 2-96 months (n=53)higher mean intake of Calcium, and more daily servings of dairy products were ASSOCIATED with lower bfskinner et al.13(2005)usalongitudinalcaucasian children, followed from 2-96 months (n=52)Intake of calcium and polyunsaturated fat were negatively ASSOCIATED with bf%dixon et al.14(2005)usalongitudinalhc non-obese children and non-hcechildren aged 4 to 10 years (n=342)Calcium Intake was inversely ASSOCIATED with bmiasum of Skinfolds and Trunk sf in non-hc children aged 7 to 10 years.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 371), ('SUPERFICIAL_RELATIONSHIP', 542), ('SUPERFICIAL_RELATIONSHIP', 693)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 47, 'calcium'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 315, 'calcium'), ('GO_0007631', 'feeding behavior', 484, 'Intake'), ('CHEBI_31341', 'calcium dihydroxide', 664, 'Calcium'), ('GO_0007631', 'feeding behavior', 672, 'intake'), ('UBERON_0009007', 'superficial inguinal lymph node', 720, 'skinfolds'), ('UBERON_0002100', 'trunk', 734, 'trunk')]
S37-PMC4516377	PMC4516377	6/2015	S37-PMC4516377	['CONSIDERING the studies that assessed the ASSOCIATION between Vitamin D and obesity in children, two were cross-sectional18,20and one longitudinal21(table 1).']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
S66-PMC4516377	PMC4516377	6/2015	S66-PMC4516377	['the mechanisms INVOLVED in the ASSOCIATION between obesity and Serum levels of Vitamin D have not been described specifically for children.figure 3shows the POSSIBLE mechanisms INVOLVED in the ASSOCIATION between Vitamin D and obesity.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
S73-PMC4516377	PMC4516377	6/2015	S73-PMC4516377	['as these FACTORS are INTERCONNECTED with worsening in the obesity context, the cause-and-effect ASSOCIATION between the two pathologies is NOT yet CLEAR.37\nlee et al.18EMPHASIZED that DIFFERENCES in Serum levels of Vitamin D in RELATION to gender CAN be EXPLAINED by the fact that girls reported having a healthier diet for all questions asked.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 96), ('FULL_UNKNOWN', 139), ('INCOMPLETE_EVIDENCE', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 228), ('INCOMPLETE_EVIDENCE', 247), ('PROBABLE_UNDERSTANDING', 254)]	9	[('UBERON_0001977', 'blood serum', 199, 'serum'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
S79-PMC4516377	PMC4516377	6/2015	S79-PMC4516377	['SOME STUDIES17,18,20that evaluated the ASSOCIATION of Calcium and Vitamin D with obesity SHOWED a cross-sectional design and it is IMPORTANT to CONSIDER the existence of SOME LIMITATIONS, especially REVERSE causality, AS the exposure and outcome are collected simultaneously.30moreover, it is IMPORTANT to TAKE INTO account that one of the STUDIES14DID not make adjustments for CONFOUNDING FACTORS in the statistical analyses, in addition to the SMALL sample size used by others,13,14which CAN lead to erroneous conclusions.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 131), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 199), ('PROBABLE_UNDERSTANDING', 218), ('IMPORTANT_CONSIDERATION', 293), ('IMPORTANT_CONSIDERATION', 306), ('INCOMPLETE_EVIDENCE', 340), ('PROBLEM_COMPLICATION', 378), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 490)]	15	[('CHEBI_22313', 'alkaline earth metal atom', 54, 'calcium'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
S82-PMC4516377	PMC4516377	6/2015	S82-PMC4516377	['final CONSIDERATIONS\nthe ASSOCIATION between Calcium and Vitamin D with obesity is COMPLEX and much REMAINS TO BE ELUCIDATED.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 25), ('DIFFICULT_TASK', 83), ('FULL_UNKNOWN', 100)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 45, 'calcium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
S85-PMC4516377	PMC4516377	6/2015	S85-PMC4516377	['all SHOW an inverse ASSOCIATION between serum Vitamin D and obesity or measures of adiposity in children, with this ASSOCIATION being INFLUENCED by the seasons of the year and gender.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 20), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
S88-PMC4516377	PMC4516377	6/2015	S88-PMC4516377	['Calcium and Vitamin D, both assessed by dietary intake and by biochemical markers, were ASSOCIATED with obesity.']	[('SUPERFICIAL_RELATIONSHIP', 88)]	1	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
S245-PMC4586450	PMC4586450	10/2015	S245-PMC4586450	['these results SUGGEST that within the range of fat intakes normally consumed by united kingdom preschool children, there is no EVIDENCE of an EFFECT on growth or obesity development of increasing the proportion of ei coming from fat in the diet.vitamin a\nthe sources of Vitamin A (Retinol equivalents) in the diet and changes in Intake between age 1.5 years and age 3.5 years were examined longitudinally (n = 755 with Food records at both ages).23the diet was categorized by core and noncore Foods, and THERE was EVIDENCE that the quality of the diet deteriorated with age.23between age 1.5 years and age 3.5 years, the dietary Intake of Vitamin A decreased by 56 µg/day (95% ci, −17 to −95 µg/d; p = 0.005) MAINLY due to decreased Intake of whole milk (390 g/d at age 1.5 y; 261 g/d at age 3.5 y) and increased Intake of energy-dense, Nutrient-poor Foods such as puddings, cakes, biscuits, confectionery, and crisps.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 514), ('PROBABLE_UNDERSTANDING', 709)]	6	[('CHEBI_27300', 'vitamin D', 270, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 281, 'retinol'), ('GO_0007631', 'feeding behavior', 329, 'intake'), ('CHEBI_33290', 'food', 419, 'food'), ('CHEBI_33290', 'food', 493, 'foods'), ('GO_0007631', 'feeding behavior', 629, 'intake'), ('CHEBI_27300', 'vitamin D', 639, 'vitamin A'), ('GO_0007631', 'feeding behavior', 733, 'intake'), ('GO_0007631', 'feeding behavior', 813, 'intake'), ('CHEBI_33284', 'nutrient', 837, 'nutrient'), ('CHEBI_33290', 'food', 851, 'foods')]
S85-PMC4613350	PMC4613350	9/2015	S85-PMC4613350	['matched for body mass index (bmi);6exclusion: Vitamin C and/or Vitamin E supplements, history of major medical complications, major fetal defects, repeated spontaneous abortion, use of an Illicit Drug or Warfarin treatment during the current Pregnancy;7inclusion: nulliparous women with singleton Pregnancies without major fetal chromosomal or structural anomaly;8exclusion: women who had a previous fetus with a chromosomal abnormality and women with Insulin-dependent diabetes mellitus;9exclusion: aids or hepatitis, cases of major fetal anomaly, fetal death and women with Placenta previa, Placenta accrete, or Placental abruption;10general population, singleton Pregnancies;11a priori high risk Pregnancies;12general population;13inclusion: singleton Pregnancy, exclusion: diabetes and chromosomal abnormalities;14exclusion: chronic Hepatic or Renal diseases, Pregnancies with major fetal abnormalities and those ending in termination, Miscarriage or fetal death <24 weeks;15exclusion : known aneuploidy and major congenital malformations;16exclusion: Miscarriages;17exclusion: congenital abnormalities or Medication use;18randomly selected controls;19exclusion: multifetal Gestation, diabetes, chromosomal or structural abnormalities;20exclusion: increased risk factors of pe, sga or ptb, known major fetal anomaly or abnormal karyotype, intervention that MAY modify Pregnancy outcome such as treatment with Aspirin or Progesterone;21inclusion: history of pe in a previous Pregnancy, chronic hypertension, chronic Renal disease, Antiphospholipid syndrome, systemic lupus erythematosus, Pregestational diabetes mellitus, obesity (bmi ≥ 30 kg/m2).']	[('INCOMPLETE_EVIDENCE', 1361)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin E'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 188, 'illicit drug'), ('CHEBI_10033', 'warfarin', 204, 'warfarin'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 297, 'pregnancies'), ('PR_000045358', 'insulin family protein', 452, 'insulin'), ('UBERON_0001987', 'placenta', 576, 'placenta'), ('UBERON_0001987', 'placenta', 593, 'placenta'), ('UBERON_0001987', 'placenta', 614, 'placental'), ('GO_0007565', 'female pregnancy', 666, 'pregnancies'), ('GO_0007565', 'female pregnancy', 699, 'pregnancies'), ('GO_0007565', 'female pregnancy', 755, 'pregnancy'), ('UBERON_0002107', 'liver', 837, 'hepatic'), ('UBERON_0002113', 'kidney', 848, 'renal'), ('GO_0007565', 'female pregnancy', 864, 'pregnancies'), ('GO_0046660', 'female sex differentiation', 940, 'miscarriage'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 1056, 'miscarriages'), ('CHEBI_60211', 'compound Z', 1110, 'medication'), ('GO_0007565', 'female pregnancy', 1178, 'gestation'), ('GO_0007565', 'female pregnancy', 1372, 'pregnancy'), ('CHEBI_2904', 'atenolol', 1413, 'aspirin'), ('CHEBI_17026', 'progesterone', 1424, 'progesterone'), ('GO_0007565', 'female pregnancy', 1478, 'pregnancy'), ('UBERON_0002113', 'kidney', 1519, 'renal'), ('CHEBI_16240', 'hydrogen peroxide', 1534, 'antiphospholipid'), ('GO_0007565', 'female pregnancy', 1591, 'pregestational')]
S119-PMC4632418	PMC4632418	10/2015	S119-PMC4632418	['besides, EARLIER STUDIES have IDENTIFIED a NUMBER OF FACTORS that INFLUENCE Serum levels of 25(Oh)D, including obesity, fat malabsorption syndrome which is UNABLE TO absorb the fat-soluble Vitamin D, medications enhancing the Catabolism of 25(Oh)D and 1,25(Oh)2D3, and so on [5].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 66), ('DIFFICULT_TASK', 156)]	6	[('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0009056', 'catabolic process', 226, 'catabolism'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('CHEBI_73394', 'Ala-Ser', 254, '25(OH)2D3')]
S84-PMC4684854	PMC4684854	12/2015	S84-PMC4684854	['obesity presents a CONFOUNDING INFLUENCE in THIS discussion, however, AS a greater bmi is ASSOCIATED with lower Vitamin D levels as well as greater Insulin resistance and risk for Gestational diabetes.']	[('PROBLEM_COMPLICATION', 19), ('SUPERFICIAL_RELATIONSHIP', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 90)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('PR_000045358', 'insulin family protein', 148, 'insulin'), ('GO_0007565', 'female pregnancy', 180, 'gestational')]
S87-PMC4719746	PMC4719746	1/2016	S87-PMC4719746	['crude mean (sd) Vitamin D [25(Oh)D in nmol/l] levels according to POTENTIAL explanatory factorsat inclusionat Gestational week 28 n \u2009=\u2009748 n \u2009=\u2009748mean(sd)mean(sd)overall mean 25(Oh)d50(27)59(29)age at inclusion\u2009\u2009\u2009≤30\xa0years47(25)55(27)\u2009\u2009\u2009>30\xa0years54(28)62(30)parity (para 0 ref)53(26)61(29)\u2009\u2009\u2009para 152(28)59(27)\u2009\u2009\u2009para ≥242(25)52(30)western europe (ref)69(24)72(28)\u2009\u2009\u2009south asia32(19)46(23)\u2009\u2009\u2009middle east34(20)51(29)\u2009\u2009\u2009sub-saharan africa38(18)45(25)\u2009\u2009\u2009east asia51(17)53(19)\u2009\u2009\u2009other56(21)63(26)season of Blood sample\u2009\u2009\u2009summer56(29)60(29)\u2009\u2009\u2009winter46(24)57(27)education level (>12\xa0years ref)60(27)67(27)\u2009\u2009\u200910-12 years46(25)56(29)\u2009\u2009\u2009<10\xa0years37(20)44(23)Vitamin D supplements\u2009\u2009\u2009≥10\xa0μga57(26)61(28)\u2009\u2009\u2009no or <10\xa0μg42(26)53(29)pre-Pregnancy bmi; kg/m2(normal weight (<25) ref)51(27)59(29)\u2009\u2009\u2009overweight (≥25/<30)51(27)61(31)\u2009\u2009\u2009obesity (≥30)48(24)54(24)\naintake of ≥10\xa0μg Vitamin D daily past two weeks\n\ncaption (fig): fig.']	[('INCOMPLETE_EVIDENCE', 66)]	1	[('CHEBI_28384', 'vitamin K', 16, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 16, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 27, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 110, 'gestational'), ('CHEBI_30778', 'gallic acid', 176, '25(OH)'), ('UBERON_0000178', 'blood', 503, 'blood'), ('CHEBI_28384', 'vitamin K', 650, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 724, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 863, 'vitamin D')]
S30-PMC4730270	PMC4730270	12/2015	S30-PMC4730270	['risks AFFECTING early-Life bp of offspring examined in these cohorts include smoking, low Vitamin D intake, Gestational hypertension, maternal obesity, short-term breastfeeding, excessive Postnatal weight gain, and undernutrition [10,11,12,13,14,15,16,17,18,19,20].']	[('SUPERFICIAL_RELATIONSHIP', 6)]	1	[('UBERON_0000104', 'life cycle', 22, 'life'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'gestational'), ('GO_0007567', 'parturition', 188, 'postnatal')]
S23-PMC4778858	PMC4778858	3/2016	S23-PMC4778858	['HOWEVER, PREVIOUS STUDIES on Birth weight outcomes and RISK of gdm among Vitamin D deficient mothers DID NOT adequately address rates of maternal obesity, used an inaccurate vitamin d assay, or studied neonates of varying Gestational ages, thus CONFOUNDING interpretation of results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 101), ('PROBLEM_COMPLICATION', 245)]	5	[('GO_0007567', 'parturition', 29, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'gestational')]
S97-PMC4811107	PMC4811107	3/2016	S97-PMC4811107	['EXAMINED WHETHER Prepregnancy obesity PREDICTED POOR Vitamin D status in neonates in their study of 400 women in pittsburgh, pennsylvania [7].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 48)]	4	[('GO_0007565', 'female pregnancy', 17, 'prepregnancy'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
S136-PMC4811441	PMC4811441	3/2016	S136-PMC4811441	['also, an increase in 25(Oh)D ≥30 nmol/l was not associated with Pregnancy-induced hypertension.10.1371/journal.pone.0152198.t004\n\ncaption (table-wrap): table 4\nbivariable and multivariable logistic regression analysis of the DETERMINANTS of Pregnancy-induced hypertension.bivariablemultivariableabor95% cipbor95% ciplowerupperlowerupper25(Oh)D t10.0081.0081.0011.0140.0240.0021.0020.9931.0100.709obesity t10.3661.4430.8972.3210.131-0.1690.8440.4641.5380.844nulliparity0.3611.4351.0391.9830.0290.2051.2280.8541.7650.269excessive gwg0.4731.6041.1462.2460.0060.3631.4380.9952.0780.054preexisting medical condition t10.6321.8810.8764.0400.1050.0891.0930.4542.6290.842assisted reproduction0.1821.2000.7881.8280.3950.0841.0880.6561.8030.745tobacco use t1-0.6330.5310.2161.3080.169-0.4470.6400.2621.5630.327height0.0541.0551.0291.083<0.0010.0351.0351.0051.0660.021age ≥40 years t1-0.1410.8680.3732.0240.744-0.1920.8250.3122.1840.699dbp t10.0871.0911.0691.114<0.0010.0881.0921.0671.117<0.001\n25(Oh)d = 25-Hydroxyvitamin D, t1 = first trimester, gwg = Gestational weight gain, dbp = diastolic Blood pressure,\ndichotomous: age ≥40 years, obesity, nulliparity, excessive gwg, preexisting medical condition and assisted reproduction\na.adjusted for multifetal Pregnancy, baseline employment status, Gestational age at t1, month of Conception and northern european country of Birth\n\ndiscussion\nthese results are the primary outcome of the gravid study–TO OUR KNOWLEDGE the FIRST STUDY reporting on the RELATIONSHIP between longitudinal Vitamin D status and its RELATION to pe and Gestational bp trajectory.']	[('SUPERFICIAL_RELATIONSHIP', 225), ('PROBABLE_UNDERSTANDING', 1438), ('INCOMPLETE_EVIDENCE', 1459), ('SUPERFICIAL_RELATIONSHIP', 1488), ('SUPERFICIAL_RELATIONSHIP', 1547)]	5	[('CHEBI_71657', 'versiconol acetate', 21, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 21, '25(OH)D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'pregnancy'), ('CHEBI_33010', 'chromide(1-)', 338, '(OH)D'), ('CHEBI_63056', 'zinc cation', 984, '25(OH'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 994, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 1043, 'gestational'), ('UBERON_0000178', 'blood', 1084, 'blood'), ('GO_0007565', 'female pregnancy', 1247, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1286, 'gestational'), ('GO_0007620', 'copulation', 1318, 'conception'), ('GO_0007567', 'parturition', 1362, 'birth'), ('CHEBI_27300', 'vitamin D', 1522, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1566, 'gestational')]
S94-PMC4944244	PMC4944244	7/2016	S94-PMC4944244	['this high prevalence of hypovitaminosis D was DUE TO age, Abdominal obesity and Metabolic syndrome AFFECTING Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 40, 'D'), ('UBERON_0000916', 'abdomen', 58, 'abdominal'), ('GO_0008152', 'metabolic process', 80, 'metabolic'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
S7-PMC4973215	PMC4973215	8/2016	S7-PMC4973215	['conclusion:\nidentification of RISK FACTORS (black race, medicaid status, obesity and lack of Prenatal Vitamin use) CAN LEAD TO OPPORTUNITIES for targeted Prenatal Vitamin supplementation to reduce the risk of neonatal Vitamin D deficiency and sga status.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('FUTURE_WORK', 127)]	4	[('GO_0007565', 'female pregnancy', 93, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 102, 'vitamin'), ('GO_0007565', 'female pregnancy', 154, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
S10-PMC4973215	PMC4973215	8/2016	S10-PMC4973215	['THUS, levels of neonates at Birth depend entirely on that of the mother and, ACCORDINGLY, SEVERAL STUDIES have CONSISTENTLY CORRELATED Cord Blood 25(Oh)D levels to those of their mothers.1,2,3,4,5,6in addition, maternal Vitamin D deficiency HAS BEEN LINKED to decreased fetal growth and Birth size in OBSERVATIONAL studies.7,8,9\nmaternal Vitamin D deficiency is PREVALENT, the extent of which CAN be INFLUENCED by many variables including skin pigmentation, sun exposure, season, age, Vitamin supplementation and obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 250), ('INCOMPLETE_EVIDENCE', 301), ('IMPORTANT_CONSIDERATION', 362), ('INCOMPLETE_EVIDENCE', 393), ('SUPERFICIAL_RELATIONSHIP', 400)]	11	[('GO_0007567', 'parturition', 28, 'birth'), ('UBERON_0002240', 'spinal cord', 135, 'cord'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007567', 'parturition', 287, 'birth'), ('CHEBI_27300', 'vitamin D', 338, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 485, 'vitamin')]
S16-PMC4973215	PMC4973215	8/2016	S16-PMC4973215	['in particular, we wanted TO EVALUATE the additive EFFECTS of race and maternal characteristics such as obesity on Vitamin D deficiency and sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
S80-PMC4973215	PMC4973215	8/2016	S80-PMC4973215	['ALTHOUGH Cord Blood 25(Oh)D levels do CORRELATE to maternal levels, FACTORS that AFFECT fetal growth MAY not be uniform throughout Pregnancy and this DIFFERENCE in timing COULD AFFECT study FINDINGS.1,3,4,5,6in addition, maternal characteristics such as obesity or pre-eclampsia COULD also AFFECT results that MAY NOT HAVE BEEN SEEN IF Vitamin D samples were obtained during early Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 81), ('INCOMPLETE_EVIDENCE', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 290), ('INCOMPLETE_EVIDENCE', 310), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 333)]	15	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 22, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D'), ('GO_0007565', 'female pregnancy', 381, 'pregnancy')]
S83-PMC4973215	PMC4973215	8/2016	S83-PMC4973215	['obesity is WELL KNOWN to be a RISK FACTOR for Vitamin D deficiency BECAUSE of a Sequestering Of Vitamin D in Adipose Tissue.35maternal obesity during Pregnancy HAS also BEEN ASSOCIATED with lower Vitamin D levels in neonates at Delivery.24,36,37,38our data are CONSISTENT and illustrate the inverse RELATIONSHIP between maternal bmi at Delivery and Vitamin D status after adjusting for confounding variables.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 299)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0051208', 'sequestering of calcium ion', 80, 'sequestering of vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 109, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007567', 'parturition', 336, 'delivery'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D')]
S359-PMC4982007	PMC4982007	8/2016	S359-PMC4982007	['we FOUND SOME EVIDENCE LINKING maternal obesity and low Micronutrient status, in particular, that of Vitamin D, Folate and B12 during Pregnancy with poorer offspring Cognitive function, SUGGESTING that maternal nutrition is IMPORTANT for optimal offspring Neurodevelopment and Long-Term Cognition.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 224)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 56, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 112, 'folate'), ('CHEBI_27778', 'abequose', 123, 'B12'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('GO_0050890', 'cognition', 166, 'cognitive'), ('GO_0007399', 'nervous system development', 256, 'neurodevelopment'), ('GO_0007040', 'lysosome organization', 277, 'long-term cognition')]
S96-PMC5014971	PMC5014971	8/2016	S96-PMC5014971	['the respondents SEEMED GENERALLY knowledgeable regarding conditions that increase the risk of Vitamin D insufficiency, such as malabsorption syndrome, Gastric bypass surgery, alcohol abuse, african american race, and obesity.']	[('ANOMALY_CURIOUS_FINDING', 16), ('PROBABLE_UNDERSTANDING', 23)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001844', 'cochlea', 151, 'gastric')]
S123-PMC5014971	PMC5014971	8/2016	S123-PMC5014971	['the majority of respondents would consider screening for specific patient conditions (e.g., Gastric bypass surgery); a lesser proportion would consider screening BECAUSE of obesity or for african american women DESPITE both of these patient characteristics being KNOWN RISK FACTORS for INADEQUATE Vitamin D status.']	[('PROBLEM_COMPLICATION', 162), ('ANOMALY_CURIOUS_FINDING', 211), ('INCOMPLETE_EVIDENCE', 263), ('SUPERFICIAL_RELATIONSHIP', 269), ('IMPORTANT_CONSIDERATION', 286)]	5	[('UBERON_0001844', 'cochlea', 92, 'gastric'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
S170-PMC5118763	PMC5118763	12/2016	S170-PMC5118763	['there is SOME EVIDENCE that high maternal Folate status in combination with low Vitamin B-12 status MAY increase the risk of obesity and Insulin resistance in the offspring (21).']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_30863', '5-azaorotic acid', 42, 'folate'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 80, 'vitamin B-12'), ('PR_000045358', 'insulin family protein', 137, 'insulin')]
S151-PMC5129897	PMC5129897	10/2016	S151-PMC5129897	['as with all ESTIMATES, these have uncertainties, including the 25(Oh)D concentration–health outcome RELATIONS used; the ESTIMATES of economic BURDENS; whether reducing risk of specific diseases would translate into the same fraction of economic BURDEN; the extent to which changing risk-modifying risk factors such as smoking, alcohol Consumption, diet, and obesity modify the relative reduction due to higher 25(Oh)D concentration; and that the analysis omitted several Vitamin D–sensitive diseases and conditions BECAUSE of LIMITED UNDERSTANDING of the EFFECTS.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 120), ('IMPORTANT_CONSIDERATION', 142), ('IMPORTANT_CONSIDERATION', 245), ('PROBLEM_COMPLICATION', 515), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 555)]	8	[('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 63, '25(OH)D'), ('GO_0007631', 'feeding behavior', 335, 'consumption'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D')]
S19-PMC5155676	PMC5155676	12/2016	S19-PMC5155676	['RISK FACTORS for Vitamin D insufficiency are WELL DESCRIBED, and include ethnicity, extensive skin covering and liberal use of sun protection, overweight/obesity, low dietary Vitamin D intake, and smoking (1,10,11), in addition to the seasonal variation that is OBSERVED at temperate latitudes (11,12).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 262)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
S21-PMC5537904	PMC5537904	7/2017	S21-PMC5537904	['PRIOR STUDIES VARY strongly in methodology, PARTICULARLY in regard to assessment of Prenatal Vitamin D intake, timing and source of 25(Oh)D measurements, a method for assessing neonatal adiposity, and CONSIDERATION of OTHER contributing factors such as maternal obesity.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 44), ('FUTURE_WORK', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218)]	5	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 138, 'D')]
S155-PMC5537904	PMC5537904	7/2017	S155-PMC5537904	['these data underscore the INCREASED RISK for both early Life Vitamin D deficiency and increased adiposity conferred to offspring by women with obesity.']	[('IMPORTANT_CONSIDERATION', 26)]	1	[('UBERON_0000104', 'life cycle', 56, 'life'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
S89-PMC5679631	PMC5679631	11/2017	S89-PMC5679631	['use of multivitamin supplements containing Vitamin D and maternal obesity were ASSOCIATED with maternal 25(Oh)D level during both low and high seasons, WHILE recruitment group was significantly ASSOCIATED with 25(Oh)D concentration ONLY during the high season.10.1371/journal.pone.0188011.t002\n\ncaption (table-wrap): table 2\nmean maternal 25(Oh)D concentration according to season of Blood sampling and use of multivitamin supplements containing Vitamin D.Blood sampling in high season of cutaneous Vitamin D productionblood sampling in low season of cutaneous Vitamin D production maternal use of multivitamin supplement containing Vitamin Dmaternal Plasma 25(Oh)d nmol/lmaternal Plasma 25(Oh)D nmol/l no (mean (sd))45.2 (17.0)30.1 (13.5)yes (mean (sd))53.3 (17.8)40.9 (16.1)p value&p = 0.000p = 0.000model # beta (95% ci)beta (95% ci) constant52.7 (47.7, 57.7)34.6 (29.5, 39.7)maternal use of multivitamin supplement containing Vitamin D (yes vs .']	[('SUPERFICIAL_RELATIONSHIP', 79), ('ANOMALY_CURIOUS_FINDING', 152), ('SUPERFICIAL_RELATIONSHIP', 194), ('INCOMPLETE_EVIDENCE', 232)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 210, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 210, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 339, '25 ... OH ... D'), ('UBERON_0000178', 'blood', 384, 'blood'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D'), ('UBERON_0000178', 'blood', 456, 'Blood'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_61716', 'alpha-Kdo-CH2OH-(2->4)-alpha-Kdo', 633, 'vitamin DMaternal'), ('UBERON_0001969', 'blood plasma', 651, 'Plasma'), ('CHEBI_63056', 'zinc cation', 658, '25(OH'), ('UBERON_0001969', 'blood plasma', 681, 'Plasma'), ('CHEBI_71657', 'versiconol acetate', 688, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 930, 'vitamin D')]
S128-PMC5758521	PMC5758521	1/2018	S128-PMC5758521	['THUS, our OBSERVED negative ASSOCIATIONS of Cord Blood Vitamin E with leptin and adiponectin SUGGEST a POTENTIAL beneficial ROLE of Vitamin E in early Life in preventing the development of childhood obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('UBERON_0009472', 'axilla', 44, 'cord blood'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin E'), ('UBERON_0000104', 'life cycle', 151, 'life')]
S106-PMC5838372	PMC5838372	3/2018	S106-PMC5838372	['limited sun exposure, regular use of sunscreens, living in northern latitudes, dark skin, obesity, extensive clothing cover, Aging, poor nutritional status, malabsorption syndromes and Medications HAVE BEEN REPORTED as RISK FACTORS for Vitamin D deficiency (1,19).']	[('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 219)]	2	[('GO_0007568', 'aging', 125, 'aging'), ('CHEBI_25441', 'mycothiols', 185, 'medications'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
S67-PMC5941617	PMC5941617	5/2018	S67-PMC5941617	['other italian data are present in literature, ALTHOUGH they SHOW SOME LIMITATIONS, regarding SMALL populations, analytic methods for 25(Oh)D, the season of recruitment, the prevalence of overweight/obesity, Vitamin D supplements, sunscreens, ethnicity, and uncovered areas of latitude.']	[('ANOMALY_CURIOUS_FINDING', 46), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 70), ('PROBLEM_COMPLICATION', 70), ('INCOMPLETE_EVIDENCE', 93)]	6	[('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 133, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
S192-PMC5941617	PMC5941617	5/2018	S192-PMC5941617	['caption (table-wrap): table 7\n\nrisk factors for Vitamin D deficiency between 1 and 18\xa0years of age• non-caucasian ethnicity with dark skin pigmentation• reduced sunlight exposure (due to lifestyle factors, chronic illness or hospitalization, COMPLEX disability, institutionalization, covering clothing for religious or cultural reasons) and/or constant use of sunscreens• international adoption• obesity• inadequate diets (i.e.']	[('DIFFICULT_TASK', 242)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
S480-PMC5941617	PMC5941617	5/2018	S480-PMC5941617	['two meta-analyses CONFIRMED that Vitamin D deficiency was ASSOCIATED with obesity in children, adolescents and Adults irrespective of age, latitude, and cut-offs used to define deficiency [439,440].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adults')]
S481-PMC5941617	PMC5941617	5/2018	S481-PMC5941617	['CONVERSELY, Vitamin D deficiency does not lead to obesity [441].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
S485-PMC5941617	PMC5941617	5/2018	S485-PMC5941617	['THUS, several authors have SUGGESTED that Vitamin D deficiency COULD play a ROLE in worsening the comorbidities of pediatric obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
S508-PMC5941617	PMC5941617	5/2018	S508-PMC5941617	['similarly, guidelines for central europe RECOMMENDED in obese children Vitamin D supplementation (1200–2000\xa0iu/day depending on severity of obesity) between september and april, or throughout the whole year IF sufficient Skin Synthesis Of Vitamin D is not ensured in the summer [20].']	[('FUTURE_WORK', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 207)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0034205', 'amyloid-beta formation', 221, 'skin synthesis of'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
S510-PMC5941617	PMC5941617	5/2018	S510-PMC5941617	['more RECENTLY, united arab emirates GUIDELINES also RECOMMENDED Vitamin D supplementation in obese children and adolescents (1200–2000\xa0iu/day DEPENDING ON severity of obesity, season and sun exposure) throughout the year IF sufficient Skin Synthesis if Vitamin D is not ensured during winter [27].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 36), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0009697', 'salicylic acid biosynthetic process', 235, 'skin synthesis'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
S566-PMC5941617	PMC5941617	5/2018	S566-PMC5941617	['veiled women) and/or constant use of sunscreens• Malabsorption syndromes• chronic therapies AFFECTING Vitamin D Metabolism• obesity• risk of pre-eclampsia• Alcohol abuse• bone pain• hypocalcemia• a previous child with rickets• Pregnant adolescents\nin the present consensus we RECOMMEND Vitamin D supplementation in all Pregnant and breastfeeding women since the beginning of Pregnancy at a dose of 600\xa0iu/day.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('FUTURE_WORK', 276)]	2	[('GO_0046661', 'male sex differentiation', 49, 'Malabsorption'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 102, 'vitamin D metabolism'), ('CHEBI_30879', 'alcohol', 156, 'Alcohol'), ('GO_0007565', 'female pregnancy', 227, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0007565', 'female pregnancy', 319, 'pregnant'), ('GO_0007565', 'female pregnancy', 375, 'pregnancy')]
S703-PMC5941617	PMC5941617	5/2018	S703-PMC5941617	['obesity and Metabolic syndrome\n\nepidemiological studies SHOWED that obese children and adolescents are at high RISK for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 111)]	2	[('GO_0008152', 'metabolic process', 12, 'metabolic'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
S704-PMC5941617	PMC5941617	5/2018	S704-PMC5941617	['obesity is the cause and not the EFFECT of this ASSOCIATION BECAUSE of the deposition of Vitamin D in Adipose Tissue with consequent reduction in Serum 25(Oh)d levels.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBLEM_COMPLICATION', 60)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 102, 'adipose tissue'), ('UBERON_0001977', 'blood serum', 146, 'serum'), ('CHEBI_30778', 'gallic acid', 152, '25(OH)')]
S706-PMC5941617	PMC5941617	5/2018	S706-PMC5941617	['we SUGGEST against Vitamin D administration to improve obesity-related COMPLICATIONS, given INCONSISTENT results and the SMALL NUMBER OF STUDIES.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 121)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
